Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced ...

Adults in their 70s with dementia experienced faster weight loss in the decade before diagnosis than their cognitively ...

In their study published in Nature Communications, researchers identified an unusual type of brain cell they named “ovoid ...

A study at Lund University reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta—a hallmark of Alzheimer's disease. The findings ...

An increased risk of dementia among individuals exposed to brain trauma, traumatic brain injury, has been known for almost a century.

Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...

Doug Whitney was supposed to develop Alzheimer's by 50. Now scientists are trying to understand why his brain remains healthy ...

When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the skin may be just as effective as traditional means of administration with ...

Leqembi (lecanemab) and Kisunla (donanemab) are proven to slow cognitive and functional decline by 27 and 35%, respectively.

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

Some two years into Leqembi’s launch, Eisai continues to go all-in on its Alzheimer’s disease-fighting antibody, which the ...

Researchers discovered that nearly 70 per cent of suspected frontotemporal dementia patients ultimately did not have the disease in a study aimed at identifying factors that contribute to misdiagnosis ...